Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -5 of 5
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
3/18/2008
1.
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Finasteride (Proscar) for the Chemoprevention of Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Prevention
Completed
55 and over
NCI
SWOG-9217
PCPT-1, NCI-P93-0049
Last Modified:
11/1/1997
 
First Published:
11/1/1997
2.
Phase II Study of Fenretinide versus Finasteride versus Placebo in Patients with Localized Prostate Cancer (Summary Last Modified 11/97)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Prevention
Closed
40 to 75
NCI
BCM-H2533
NCI-P97-0107
Last Modified:
9/26/2006
 
First Published:
6/1/1998
3.
Phase II Study of Flutamide and Finasteride in Patients with Elevated Serum PSA After Radiation Therapy or Radical Prostatectomy for Adenocarcinoma of the Prostate
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care, Treatment
Closed
Not specified
NCI
CLB-9782
NCT00003323, CALGB-9782
Last Modified:
6/1/1989
4.
Phase II Pilot Randomized, Double-Blind Study of MK-906 vs Placebo in Patients with Stage D Adenocarcinoma of the Prostate (Summary Last Modified 06/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
40 to 85
MSKCC-88142
NCI-V89-0048
Last Modified:
9/1/1991
5.
Phase II Randomized, Double-Blind Study of Finasteride (MK-906) vs Placebo in Patients with Prostate Cancer Following Radical Prostatectomy (Summary Last Modified 09/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
no age specified
MSKCC-90127
NCI-V91-0098
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute